Article
SNPD-siKRAS: siRNA specifically inhibits KRAS with a single-nucleotide mutation
2025-09-20
Abstract excerpt
<h4>SUMMARY</h4> Kirsten Rat Sarcoma Viral Oncogene Homolog ( KRAS ) is the most frequently mutated gene associated with pancreatic cancer. However, targeting mutated KRAS without affecting the wild-type KRAS expression by conventional chemotherapy is challenging, because KRAS protein is considered to be undruggable due to the lack of surface structures for drug binding. Here, we developed a single-nucleotide...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8c853b5-1c17-57be-bf50-37787859c267
- DOI
- 10.1101/2025.09.18.677211
